Angiotensin-(1-7) and angiotensin-(1-9): function in cardiac and vascular remodelling (Q38193206)

30 August 2017

1 reference

title

Angiotensin-(1-7) and angiotensin-(1-9): function in cardiac and vascular remodelling (English)

1 reference

30 August 2017

1 reference

ChEBI release 2020-05-28

ChEBI ID

80128

author

Christopher M. Loughrey

object named as

Christopher M Loughrey

3

0 references

Stuart A Nicklin

object named as

Stuart A Nicklin

5

0 references

author name string

Clare A McKinney

1

1 reference

30 August 2017

Caroline Fattah

2

1 reference

30 August 2017

Graeme Milligan

4

1 reference

30 August 2017

language of work or name

English

0 references

publication date

1 June 2014

1 reference

30 August 2017

1 reference

30 August 2017

volume

126

1 reference

30 August 2017

issue

12

1 reference

30 August 2017

page(s)

815-827

1 reference

Effect of statins, angiotensin-converting enzyme inhibitors, and beta blockers on survival in patients >or=65 years of age with heart failure and preserved left ventricular systolic function

30 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1042%2FCS20130436

Conversion of angiotensin I to angiotensin II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130436

Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130436

The angiotensin II type 2 (AT2) receptor antagonizes the growth effects of the AT1 receptor: gain-of-function study using gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130436

Functional role of angiotensin II AT2 receptor in modulation of AT1 receptor‐mediated contraction in rat uterine artery: involvement of bradykinin and nitric oxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130436

AT(2) receptor-dependent vasodilation is mediated by activation of vascular kinin generation under flow conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130436

Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130436

Quantitative mRNA expression profiling of ACE 2, a novel homologue of angiotensin converting enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130436

A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130436

A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130436

Evaluation of angiotensin-converting enzyme (ACE), its homologue ACE2 and neprilysin in angiotensin peptide metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130436

Relationship between angiotensin-(1-7) and angiotensin II correlates with hemodynamic changes in human liver cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130436

Angiotensin-(1-7) attenuates neointimal formation after stent implantation in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130436

Angiotensin converting enzyme-2 confers endothelial protection and attenuates atherosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130436

Vasoprotective and atheroprotective effects of angiotensin (1-7) in apolipoprotein E-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130436

Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130436

Relative affinity of angiotensin peptides and novel ligands at AT1 and AT2 receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130436

Evidence for a functional interaction of the angiotensin-(1-7) receptor Mas with AT1 and AT2 receptors in the mouse heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130436

Angiotensin-(1-7) acts as a vasodepressor agent via angiotensin II type 2 receptors in conscious rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130436

Differential mechanisms of ang (1-7)-mediated vasodepressor effect in adult and aged candesartan-treated rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130436

Hemodynamic effects of vasorelaxant compounds in mice lacking one, two or all three angiotensin II receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130436

Angiotensin 1-9 and 1-7 release in human heart: role of cathepsin A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130436

Enalapril attenuates downregulation of Angiotensin-converting enzyme 2 in the late phase of ventricular dysfunction in myocardial infarcted rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130436

ACEH/ACE2 is a novel mammalian metallocarboxypeptidase and a homologue of angiotensin-converting enzyme insensitive to ACE inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130436

Angiotensin1-9 antagonises pro-hypertrophic signalling in cardiomyocytes via the angiotensin type 2 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130436

The elusive nature of intrinsic efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130436

Discovery and characterization of alamandine: a novel component of the renin-angiotensin system

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130436

Adaptive and maladaptive hypertrophic pathways: points of convergence and divergence

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130436

Alteration of sarcoplasmic reticulum Ca2+ release termination by ryanodine receptor sensitization and in heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130436

TGF-beta1 mediates the hypertrophic cardiomyocyte growth induced by angiotensin II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130436

Matrix control of transforming growth factor-β function

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130436

Regional mechanics determine collagen fiber structure in healing myocardial infarcts

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130436

Angiotensin-converting enzyme 2 is an essential regulator of heart function

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130436

Loss of angiotensin-converting enzyme 2 accelerates maladaptive left ventricular remodeling in response to myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130436

Loss of angiotensin-converting enzyme-2 exacerbates diabetic cardiovascular complications and leads to systolic and vascular dysfunction: a critical role of the angiotensin II/AT1 receptor axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130436

Onset of experimental severe cardiac fibrosis is mediated by overexpression of Angiotensin-converting enzyme 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130436

Heart block, ventricular tachycardia, and sudden death in ACE2 transgenic mice with downregulated connexins

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130436

Decreased cardiac Ang-(1-7) is associated with salt-induced cardiac remodeling and dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130436

Angiotensin-(1-7) receptor Mas is an essential modulator of extracellular matrix protein expression in the heart.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130436

Chronic angiotensin-(1-7) prevents cardiac fibrosis in DOCA-salt model of hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130436

Attenuation of isoproterenol-induced cardiac fibrosis in transgenic rats harboring an angiotensin-(1-7)-producing fusion protein in the heart.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130436

Expression of an angiotensin-(1-7)-producing fusion protein produces cardioprotective effects in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130436

Angiotensin(1-7) Blunts Hypertensive Cardiac Remodeling by a Direct Effect on the Heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130436

Lentivirus-mediated overexpression of angiotensin-(1-7) attenuated ischaemia-induced cardiac pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130436

Angiotensin-(1-7) binds to specific receptors on cardiac fibroblasts to initiate antifibrotic and antitrophic effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130436

Angiotensin-(1-7) abrogates mitogen-stimulated proliferation of cardiac fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130436

Angiotensin-converting enzyme 2 activation protects against hypertension-induced cardiac fibrosis involving extracellular signal-regulated kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130436

Angiotensin-converting enzyme 2 suppresses pathological hypertrophy, myocardial fibrosis, and cardiac dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130436

Angiotensin-(1-7) upregulates cardiac nitric oxide synthase in spontaneously hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130436

Angiotensin-(1-9) regulates cardiac hypertrophy in vivo and in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130436

Angiotensin-(1-9) attenuates cardiac fibrosis in the stroke-prone spontaneously hypertensive rat via the angiotensin type 2 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130436

Recent progress in angiotensin II type 2 receptor research in the cardiovascular system

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130436

Signal transduction from the angiotensin II AT2 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130436

Angiotensin II signaling via type 2 receptors in a human model of vascular hyporeactivity: implications for hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130436

Myofibroblast-mediated mechanisms of pathological remodelling of the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130436

Angiotensin II-mediated adaptive and maladaptive remodeling of cardiomyocyte excitation-contraction coupling

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130436

Angiotensin-(1-7) prevents cardiomyocyte pathological remodeling through a nitric oxide/guanosine 3',5'-cyclic monophosphate-dependent pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130436

Cardioprotective effects mediated by angiotensin II type 1 receptor blockade and enhancing angiotensin 1-7 in experimental heart failure in angiotensin-converting enzyme 2-null mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130436

Angiotensin-(1-7): cardioprotective effect in myocardial ischemia/reperfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130436

Angiotensin (1-7) re-establishes impulse conduction in cardiac muscle during ischaemia-reperfusion. The role of the sodium pump

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130436

Angiotensin-(1-7) prevents atrial fibrosis and atrial fibrillation in long-term atrial tachycardia dogs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130436

Molecular Mechanisms Involved in the Angiotensin-(1-7)/Mas Signaling Pathway in Cardiomyocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130436

Circulating rather than cardiac angiotensin-(1-7) stimulates cardioprotection after myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130436

Angiotensin-converting enzyme 2 priming enhances the function of endothelial progenitor cells and their therapeutic efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130436

Activation of the ACE2/angiotensin-(1-7)/Mas receptor axis enhances the reparative function of dysfunctional diabetic endothelial progenitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130436

Phase I/II dose escalation study of angiotensin 1-7 [A(1-7)] administered before and after chemotherapy in patients with newly diagnosed breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130436

Atherosclerosis — An Inflammatory Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130436

Enhanced superoxide production in experimental venous bypass graft intimal hyperplasia: role of NAD(P)H oxidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130436

Pleiotropic AT1 receptor signaling pathways mediating physiological and pathogenic actions of angiotensin II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130436

State-of-the-Art lecture. Antiproliferative actions of angiotensin-(1-7) in vascular smooth muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130436

Different effects of angiotensin II and angiotensin-(1-7) on vascular smooth muscle cell proliferation and migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130436

Angiotensin-(1-7) dose-dependently inhibits atherosclerotic lesion formation and enhances plaque stability by targeting vascular cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130436

AVE 0991, a nonpeptide mimic of the effects of angiotensin-(1-7) on the endothelium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130436

AVE0991, a Nonpeptide Compound, Attenuates Angiotensin II-Induced Vascular Smooth Muscle Cell Proliferation via Induction of Heme Oxygenase-1 and Downregulation of p-38 MAPK Phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130436

Short-term angiotensin(1-7) receptor MAS stimulation improves endothelial function in normotensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130436

Angiotensin-(1-7) through receptor Mas mediates endothelial nitric oxide synthase activation via Akt-dependent pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130436

Chronic treatment with angiotensin-(1-7) improves renal endothelial dysfunction in apolipoproteinE-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130436

The antithrombotic effect of angiotensin-(1-7) involves mas-mediated NO release from platelets

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130436

Design and evaluation of cyclodextrin-based drug formulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130436

An orally active formulation of angiotensin-(1-7) produces an antithrombotic effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130436

Rho kinase inhibition activates the homologous angiotensin-converting enzyme-angiotensin-(1-9) axis in experimental hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130436

A novel mechanism for angiotensin II formation in streptozotocin-diabetic rat glomeruli

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130436

Angiotensin-(1-7) counterregulates angiotensin II signaling in human endothelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130436

Endothelial Nox4 NADPH oxidase enhances vasodilatation and reduces blood pressure in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130436

AVE 0991, a non-peptide mimic of angiotensin-(1-7) effects, attenuates pulmonary remodelling in a model of chronic asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130436

Renoprotective Effects of AVE0991, a Nonpeptide Mas Receptor Agonist, in Experimental Acute Renal Injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130436

Formation of angiotensin II and other angiotensin peptides from des-leu 10-angiotensin I in rat lung and kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130436

Angiotensin-converting enzyme 2 (ACE2) expression and activity in human carotid atherosclerotic lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130436

21 January 2018

Identifiers

DOI

10.1042/CS20130436

1 reference

30 August 2017

1 reference